돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 362608생성일: 2026년 10월 26일

Dicyclohexylcarbodiimide → (R)-9-[4-(N-BOC-L-isoleucyloxy)-2-(stearoyloxymethyl)butyl]guanine

https://huagongshe.com/reaction/362608

반응식

참여 물질

역할이름HCID투입량
반응물DicyclohexylcarbodiimideHCID 10868—
반응물tert-Butoxycarbonyl-L-isoleucineHCID 2724762—
반응물(R)-9-[4-hydroxy-2-(stearoyloxymethyl)butyl]guanineHCID 135481053—
촉매4-(Dimethylamino)pyridineHCID 14284—
용매DimethylformamideHCID 6228—
생성물(R)-9-[4-(N-BOC-L-isoleucyloxy)-2-(stearoyloxymethyl)butyl]guanineHCID 136377418—

반응 단계

(R)-9-[4-Hydroxy-2-(stearoyloxymethyl)butyl]guanine (135 mg, 0.26 mmole) and N-BOC-L-isoleucine (180 mg, 0.78 mmole) was coevaporated with dry DMF twice and dissolved in the same solvent (3.5 ml). To the solution was added 1,3-dicyclohexylcarbodiimide (160 mg, 0.78 mmole) and 4-dimethylaminopyridine (4.8 mg, 0.039 mmole). After reaction for 18 hours, the reaction mixture was filtered through Celite and worked up in a conventional manner. The product was isolated by silica gel column chromatography, eluting at 5% MeOH in CH2Cl2. (Yield 160 mg)

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05869493
출처 데이터셋uspto-grants-1999_02
ORD IDord-a5f5c2d624084335af5f319bdf58ce80
출처 메모uspto-grants-1999_02